Using a fundus camera, the trained operator captures two images per eye
The images are submitted to IDx-DR
IDx-DR analyzes images for signs of diabetic retinopathy and macular edema, providing results in less than 30 seconds
No disease detected: Retest in 12 Months
Disease detected: Refer to an eye care professional
Our Approach to AI Driven Diagnostics
AI the Right Way
IDx-DR was modeled to think like a physician and make decisions based on the same clinical disease detectors that eye care specialists would use.
High Performance in a
Real-World Clinical Setting
IDx-DR has been trained and validated on over 2M images to mitigate bias and ensure the system works equally well for all people, regardless of sex, race, or ethnicity. For more information, read our pivotal trial.
IDx-DR in Action
Digital Diagnostics is impacting patient care across the globe.
Front-Line Care Providers
Medical professionals are able to provide patients with diagnostic results at point-of-care allowing for more comprehensive care and same-day specialty referrals. Not only that, front-line care providers have an opportunity for increased compliance with quality metrics and new revenue streams.
Ophthalmologists & Optometrists
Specialty eyecare providers can utilize IDx-DR to address their patient backlog in addition to identifying patients with disease that would never have been seen otherwise. IDx-DR facilitates more actionable referrals of the treatable disease allowing more time for higher yield procedures.
IDx-DR is installed at point-of-care locations, increasing patient access and convenience while potentially lowering costs.
Indications for Use - US
IDx-DR is intended for use by health care providers to automatically detect more than mild diabetic retinopathy (mtmDR) in adults (22 years of age or older) diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy. IDx-DR is indicated for use with the Topcon NW400
Indications for Use - EU
IDx-DR is intended for use by health care providers to automatically detect more than mild diabetic retinopathy (mtmDR) in adults diagnosed with diabetes who have not been previously diagnosed with diabetic retinopathy.